Nope...not enough. This will get sub-dollar pretty soon. Other than a not so appealing drug in the pipeline this company has nothing. The oncology drug was the value and the value has been removed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.